These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary amylase, urinary insulin, or urinary thromboxane: which is the best predictor of pancreatic allograft rejection in the dog? Odor-Morales A; Lopez RM; Luque E; Chavira SC; Sotres A; Larriva J; de la Rosa-Laris C; Chavez-Peon F Transplant Proc; 1990 Apr; 22(2):709-11. PubMed ID: 1691549 [No Abstract] [Full Text] [Related]
3. Pancreatic juice neopterin excretion--reliable marker for detection of pancreatic allograft rejection. Königsrainer A; Reibnegger G; Ofner D; Klima G; Tauscher T; Margreiter R Transplant Proc; 1990 Apr; 22(2):671-2. PubMed ID: 1691547 [No Abstract] [Full Text] [Related]
5. Urinary thromboxane and 6-keto-prostaglandin F1 alpha are early markers of acute rejection in experimental pancreas transplantation. Johnson BF; Wiley KN; Greaves M; Preston FE; Fox M; Raftery AT Transplantation; 1994 Jul; 58(1):18-23. PubMed ID: 7518618 [No Abstract] [Full Text] [Related]
12. Urinary thromboxane B2 as indicator of pancreatic allograft rejection in nonimmunosuppressed dogs. Odor-Morales A; López-Medrano RM; Larriva Sahd J; López-Graniel CM; Rodríguez-Sancho LC; Luque-de León E; Campos-de la Borbolla L; Belkind-Gerson J; Chavira-Estefan S; de la Rosa-Laris C Transplant Proc; 1989 Aug; 21(4):3646-9. PubMed ID: 2669272 [No Abstract] [Full Text] [Related]
13. LTC4, thromboxane B2 and 6-keto PGF1 in syngeneic and allogenic heterotopic cardiac transplant in rats. Pepino P; LeCren G; Barr ML; Cannon PJ; Hardy MA Transplant Proc; 1989 Feb; 21(1 Pt 1):442. PubMed ID: 2650170 [No Abstract] [Full Text] [Related]
14. Urinary amylase and immunoreactive metabolites of thromboxane B2 and 6keto-prostaglandin F1 alpha in rat pancreatic allograft rejection. Johnson BF; Webster MJ; Wiley KN; Herold A; Fox M; Raftery AT Transplant Proc; 1989 Feb; 21(1 Pt 3):2788-90. PubMed ID: 2468239 [No Abstract] [Full Text] [Related]
15. Penetration of ciprofloxacin and ofloxacin into pancreatic juice. Brattström C; Malborg AS; Tydén G Chemioterapia; 1987 Jun; 6(2 Suppl):295-7. PubMed ID: 3334568 [No Abstract] [Full Text] [Related]
16. Posttransplant hyperamylasemia is associated with decreased patient and graft survival in pancreas allograft recipients. Cheng SS; Munn SR Transplant Proc; 1994 Apr; 26(2):428-9. PubMed ID: 7513452 [No Abstract] [Full Text] [Related]
17. Monitoring of the pancreatic allograft by analysis of exocrine secretion. Steiner E; Klima G; Niederwieser D; Königsrainer A; Herold M; Margreiter R Transplant Proc; 1987 Feb; 19(1 Pt 3):2336-8. PubMed ID: 3547929 [No Abstract] [Full Text] [Related]
18. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO Transplant Proc; 1994 Apr; 26(2):531-3. PubMed ID: 7513455 [No Abstract] [Full Text] [Related]
19. The exocrine secretions of the grafted pancreas. Sato J; Darley-Usmar V; Fukutomi H; Osuga T; Fukao K Transplant Proc; 1989 Jun; 21(3):3449-51. PubMed ID: 2662487 [No Abstract] [Full Text] [Related]